recombinant factor therapy

Recombinant factor therapy involves producing clotting factors—the proteins the body needs to stop bleeding—using genetically engineered cells. Instead of relying on donated blood products, scientists insert human gene instructions for these factors into bacteria or cells in a lab, which then produce the proteins. These lab-made clotting factors are purified and used to treat people with bleeding disorders like hemophilia. This method reduces the risk of transmitting infections and ensures a steady, controlled supply of the necessary proteins to prevent or control bleeding episodes effectively.